An Introduction to CAR-T and Bispecifics

Dr. Nausheen Ahmed provides a basic overview of the cutting-edge treatment known as Chimeric Antigen Receptor T-cell therapy (CAR-T therapy), and sheds light on it’s innovative nature to precisely target and neutralize cancer cells. She also discuss Bispecific T Cell Engagers which are engineered proteins that enhance the immune response against cancer cells. Both CAR-T and T Cell Engagers are extremely promising approaches in the treatment of cancers: Overview of CAR-T and Bispecifics .